Similarly, the mTOR pathway was studied in a preclinical rat chondrosarcoma model by utilizing the mTOR inhibitor everolimus which blocked cell proliferation as well as GLUT1 and HIF1a expression in vivo (58). Here, HIF1A is linked to chondrosarcoma.